Maccura Biotechnology Co Ltd (SHE:300463) — Stock Price

CN¥9.42 CNY
▲ 0.75% today

Maccura Biotechnology Co Ltd (SHE:300463) is currently trading at CN¥9.42 CNY, up 0.75% today. Over the past 52 weeks, shares have ranged between CN¥8.11 and CN¥14.20. This page tracks Maccura Biotechnology Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 300463 market cap overview.

Maccura Biotechnology Co Ltd (300463) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Maccura Biotechnology Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Maccura Biotechnology Co Ltd Income Statement — Revenue, Profit & Earnings by Year

Maccura Biotechnology Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥2.17 Billion CN¥2.55 Billion CN¥2.90 Billion CN¥3.61 Billion CN¥3.98 Billion
Cost of Revenue CN¥890.54 Million CN¥1.17 Billion CN¥1.38 Billion CN¥1.71 Billion CN¥1.74 Billion
Gross Profit CN¥1.28 Billion CN¥1.38 Billion CN¥1.51 Billion CN¥1.90 Billion CN¥2.24 Billion
Research & Development CN¥317.94 Million CN¥323.15 Million CN¥324.17 Million CN¥273.22 Million CN¥207.27 Million
SG&A CN¥297.75 Million CN¥165.13 Million CN¥184.23 Million CN¥155.77 Million CN¥168.40 Million
Total Operating Expenses CN¥2.12 Billion CN¥1.21 Billion CN¥1.18 Billion CN¥1.08 Billion CN¥1.03 Billion
Operating Income CN¥54.76 Million CN¥169.97 Million CN¥331.14 Million CN¥817.39 Million CN¥1.21 Billion
EBITDA — CN¥582.02 Million CN¥626.55 Million CN¥1.07 Billion CN¥1.46 Billion
EBIT — CN¥262.16 Million CN¥331.60 Million CN¥815.54 Million CN¥1.24 Billion
Interest Expense CN¥21.54 Million CN¥23.04 Million CN¥34.45 Million CN¥35.63 Million CN¥60.69 Million
Income Before Tax CN¥-99.54 Million CN¥124.65 Million CN¥305.37 Million CN¥789.08 Million CN¥1.19 Billion
Income Tax Expense — CN¥5.89 Million CN¥689.90K CN¥87.38 Million CN¥184.88 Million
Net Income CN¥-35.83 Million CN¥126.81 Million CN¥312.62 Million CN¥708.18 Million CN¥956.60 Million

Maccura Biotechnology Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Maccura Biotechnology Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥7.99 Billion CN¥7.98 Billion CN¥8.12 Billion CN¥8.16 Billion CN¥6.57 Billion
Total Current Assets CN¥3.23 Billion CN¥3.64 Billion CN¥4.22 Billion CN¥4.70 Billion CN¥3.86 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥50.18 Million CN¥60.06 Million CN¥311.14 Million CN¥663.72 Million —
Net Receivables CN¥1.14 Billion CN¥1.61 Billion CN¥1.86 Billion CN¥2.16 Billion CN¥1.95 Billion
Inventory CN¥849.13 Million CN¥901.58 Million CN¥907.49 Million CN¥1.04 Billion CN¥1.08 Billion
Property, Plant & Equipment — — — CN¥2.51 Billion CN¥2.02 Billion
Goodwill CN¥51.04 Million CN¥51.04 Million CN¥145.15 Million CN¥145.15 Million CN¥21.32 Million
Total Liabilities CN¥1.69 Billion CN¥1.55 Billion CN¥1.51 Billion CN¥1.63 Billion CN¥2.03 Billion
Total Current Liabilities CN¥1.05 Billion CN¥1.20 Billion CN¥1.12 Billion CN¥1.08 Billion CN¥1.31 Billion
Long-term Debt CN¥521.87 Million CN¥184.12 Million CN¥162.50 Million CN¥285.80 Million CN¥424.10 Million
Net Debt CN¥113.64 Million CN¥-225.45 Million CN¥-170.79 Million CN¥113.87 Million CN¥478.29 Million
Total Stockholder Equity CN¥6.28 Billion CN¥6.37 Billion CN¥6.38 Billion CN¥6.29 Billion CN¥4.30 Billion
Retained Earnings CN¥3.77 Billion CN¥3.87 Billion CN¥3.84 Billion CN¥3.74 Billion CN¥3.35 Billion

Maccura Biotechnology Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Maccura Biotechnology Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥602.33 Million CN¥633.80 Million CN¥912.09 Million CN¥843.22 Million CN¥1.62 Billion
Capital Expenditures CN¥749.07 Million CN¥963.02 Million CN¥877.90 Million CN¥987.74 Million CN¥601.78 Million
Free Cash Flow CN¥-146.74 Million CN¥-329.22 Million CN¥23.61 Million CN¥-144.52 Million CN¥1.01 Billion
Investing Cash Flow — CN¥-677.47 Million CN¥-513.62 Million CN¥-1.83 Billion CN¥-686.81 Million
Financing Cash Flow — CN¥-126.78 Million CN¥-152.75 Million CN¥930.05 Million CN¥-894.69 Million
Dividends Paid CN¥-83.74 Million CN¥115.19 Million CN¥244.64 Million CN¥286.64 Million CN¥238.44 Million
Stock-Based Compensation — — — — CN¥1.05 Million
Depreciation CN¥368.79 Million CN¥336.58 Million CN¥317.82 Million CN¥270.20 Million CN¥236.20 Million
Change in Cash CN¥18.31 Million CN¥-170.26 Million CN¥247.07 Million CN¥-51.38 Million CN¥33.02 Million

Maccura Biotechnology Co Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Maccura Biotechnology Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 30, 2026 0.01 — —
Oct 25, 2025 0.01 — —
Aug 01, 2025 0.02 — —
Apr 28, 2025 0.04 — —
Oct 22, 2024 0.13 — —
Aug 01, 2024 0.13 — —
Apr 24, 2024 0.07 — —
Oct 25, 2023 0.15 — —